BOSTON, Oct. 16, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today at the 84th American Society of Plastic Surgeons annual scientific conference, Plastic Surgery: The Meeting, announced the introduction of Eikon™ LT with Tissue Grip to its illuminated retractor platform. Invuity's latest innovation expands clinical applicability and enables broader adoption in the plastic surgery market.
Expanding on the company's Eikon LT platform of non-conductive illuminated retractor systems, Eikon LT with Tissue Grip features atraumatic teeth on the distal tip of the retractor blade. This feature provides plastic surgeons the additional grip needed to create the desired breast pocket underneath the pectoral muscle for placement of a tissue expander or implant during surgery, while minimizing tissue trauma. All Eikon LT devices integrate Invuity's Intelligent Photonics™ technology to offer superior intra-cavity illumination and visualization.
Eikon LT with Tissue Grip addresses key safety priorities for hospitals and health systems. The non-conductive material eliminates the risk of potential burns due to arcing from electrosurgical devices, thus improving patient safety. This material, coupled with Invuity's proprietary thermally cool illumination, virtually eliminates the known thermal hazards associated with traditional electrosurgical devices and fiber optics. Furthermore, all devices in the platform feature a lightweight, ergonomic design that reduces surgeon fatigue and provides surgical precision.
"With more women undergoing immediate breast reconstruction after breast cancer surgery, now more than ever, we need surgical technologies that enable us to operate with greater precision and safety," said C. Andrew Salzberg, MD, Associate Professor of Plastic Surgery, and the Director of Integrated Plastic Surgery Services at the Mount Sinai Health System in New York City and the Chief of Plastic Surgery at St. John's Riverside Hospital at Dobbs Ferry in Westchester. "Eikon LT with Tissue Grip allows me to operate more efficiently and give patients the cosmetic results they desire without the risk of thermal injury."
For more information, please visit booth #232 at Plastic Surgery: The Meeting 2015 or http://invuity.com/products/retractors/eikon-lt.
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during minimally invasive and minimal access open surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding market opportunities and potential results from future new initiatives. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the Securities and Exchange Commission, including, without limitation, under the captions: "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk Factors," which are on file with the Securities and Exchange Commission.
SOURCE Invuity, Inc.